Fortrea Holdings Inc.'s revenue has held flat over three years. Revenue growth, 3-year annual rate: −0.09% (Biotechnology median +21%). Years of annual history on file: 5, FY2021 to FY2025, as filed.

FTREFortrea Holdings Inc.

Healthcare

$23.63+148% 1Y

$23.63

$8.8752 weeks$24.04

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+33.8 points), but revenue shrinking (−2% year on year).

1 good, 1 to watch, 1 without data

Revenue trend−2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+33.8 points operating

Trailing-twelve-month operating margin, -0.4% now against -34.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 80% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.